The membrane protein TIG1 binds and stabilizes AXL in breast cancer, preventing its proteasomal degradation leading to enhanced proliferative, migratory, and invasive abilities via activation of NF-κB and MMP-9 [35]. Here, AXL is linked to breast carcinoma.